NO20052925L - Vannloselige anioniske bakterieklorofyllderivater og deres anvendelse - Google Patents

Vannloselige anioniske bakterieklorofyllderivater og deres anvendelse

Info

Publication number
NO20052925L
NO20052925L NO20052925A NO20052925A NO20052925L NO 20052925 L NO20052925 L NO 20052925L NO 20052925 A NO20052925 A NO 20052925A NO 20052925 A NO20052925 A NO 20052925A NO 20052925 L NO20052925 L NO 20052925L
Authority
NO
Norway
Prior art keywords
water
chlorophyll derivatives
soluble anionic
bacterial chlorophyll
bchler
Prior art date
Application number
NO20052925A
Other languages
English (en)
Other versions
NO20052925D0 (no
NO334978B1 (no
Inventor
Avigdor Scherz
Hugo Scheer
Alexander Brandis
Yoram Salomom
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30011928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20052925(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20052925L publication Critical patent/NO20052925L/no
Publication of NO20052925D0 publication Critical patent/NO20052925D0/no
Publication of NO334978B1 publication Critical patent/NO334978B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08—Copper compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006—Palladium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006—Palladium compounds
    • C07F15/0066—Palladium compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04—Nickel compounds
    • C07F15/045—Nickel compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/06—Zinc compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

Forehggende oppfirmelse tilveiebringer anioniske vannløsehge tettasykhske og pentasykliske bakterieklorofyll- derivater (Bchler) som irmeholder minst en, foretrukket to eller tte, negativt ladede grupper og/eller sure grupper som omdannes til negativt ladede grupper ved fysiologisk pH, foretrukket Bchler som har en gruppe COO", COS", SO3", PO3 ^", COOH, COSH, SO3H og/eller PO3H2 bundet gjermom en ester- eller amidbinding tU en eller flere av posisjonene som 17^, 13^ og 3^ til det tetiasykliske eller pentasykliske Bchl-molekylet, for fotodynamisk behandling og diagnose.
NO20052925A 2002-11-17 2005-06-15 Vannløselig anionisk bakterieklorofyllderivat, fremgangsmåte for fremstilling derav, farmasøytisk sammensetning som inneholder nevnte derivat og anvendelse derav. NO334978B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL15290002A IL152900A0 (en) 2002-11-17 2002-11-17 Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
PCT/IL2003/000973 WO2004045492A2 (en) 2002-11-17 2003-11-17 Water-soluble anionic bacteriochlorophyll derivatives and their uses

Publications (3)

Publication Number Publication Date
NO20052925L true NO20052925L (no) 2005-06-15
NO20052925D0 NO20052925D0 (no) 2005-06-15
NO334978B1 NO334978B1 (no) 2014-08-11

Family

ID=30011928

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20052925A NO334978B1 (no) 2002-11-17 2005-06-15 Vannløselig anionisk bakterieklorofyllderivat, fremgangsmåte for fremstilling derav, farmasøytisk sammensetning som inneholder nevnte derivat og anvendelse derav.
NO2018012C NO2018012I1 (no) 2002-11-17 2018-04-10 Padeliporfin

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2018012C NO2018012I1 (no) 2002-11-17 2018-04-10 Padeliporfin

Country Status (23)

Country Link
US (6) US7947672B2 (no)
EP (2) EP2522349A1 (no)
JP (3) JP4922559B2 (no)
CN (2) CN1741801B (no)
AU (1) AU2003282354C1 (no)
BE (1) BE2018C018I2 (no)
BR (1) BRPI0316319B8 (no)
CA (1) CA2506296C (no)
CY (2) CY1115458T1 (no)
DK (1) DK1567147T3 (no)
ES (1) ES2489516T3 (no)
FR (1) FR18C0002I2 (no)
HU (1) HUS1800020I1 (no)
IL (2) IL152900A0 (no)
LU (1) LUC00073I2 (no)
MX (1) MXPA05005262A (no)
NL (1) NL300934I2 (no)
NO (2) NO334978B1 (no)
NZ (1) NZ540790A (no)
PL (1) PL216661B1 (no)
PT (1) PT1567147E (no)
RU (1) RU2353624C2 (no)
WO (1) WO2004045492A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
EP2322173B1 (en) * 2004-06-07 2016-08-10 Yeda Research And Development Co., Ltd. Cationic bacteriochlorophyll derivatives and uses thereof
US9957293B2 (en) * 2006-08-23 2018-05-01 Yeda Research And Development Company Ltd. Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
DK2257309T3 (da) 2008-02-27 2020-01-20 Yeda Res And Development Company Ltd Rgd-(bakterie)chlorophyl-konjugater til anvendelse ved diagnose af tumorer, der omfatter nekrotiske domæner
EP2425873A1 (fr) 2010-09-07 2012-03-07 Steba Maor SA Modélisation de l'action d'une fibre optique dans un traitement par therapie photodynamique, et assistance à la planification d'un tel traitement
MX348164B (es) 2011-03-11 2017-06-01 Steba Maor Sa Metodos de terapia fotodinamica focal.
CA2846011C (en) 2011-08-23 2019-10-15 Yeda Research And Development Co.Ltd. (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders
US10087474B2 (en) 2013-03-11 2018-10-02 Tookad Ip Sarl Method for producing bacteriochlorophyll a
EP2976347B1 (en) 2013-03-15 2022-01-19 McFarland, Sherri Ann Metal-based coordination complexes as photodynamic compounds and their use
KR20190008206A (ko) * 2016-04-10 2019-01-23 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 암 치료를 위한 병용요법
CN107987081B (zh) * 2016-10-26 2019-12-06 刘辉 一种二氢卟吩e6衍生物及其药学上可接受的盐、其制备方法和应用
AU2017384348B2 (en) * 2016-12-22 2024-03-07 Daiichi Sankyo Company, Limited Peptide for treating age-related macular degeneration
US10933134B2 (en) 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer
EP3723785A1 (en) * 2017-12-17 2020-10-21 Yeda Research and Development Co. Ltd Cop9 signalosome (csn) complex modulators and uses thereof
CN111848656B (zh) * 2020-06-24 2023-03-14 天津大学 离子修饰的原卟啉镓化合物及其制备方法和应用
US20230277604A1 (en) * 2020-07-29 2023-09-07 Japan Advanced Institute Of Science And Technology Therapeutic agent or diagnostic agent for cancer
CN115843960A (zh) * 2022-11-03 2023-03-28 中国农业科学院农产品加工研究所 一种提高叶绿素稳定性的方法
IL311461A (en) * 2024-03-13 2025-10-01 Impact Biotech Ltd Process for preparing bacteriophophorbid derivatives and their alkali metal salts

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512762A (en) 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
JPS63196586A (ja) * 1987-02-12 1988-08-15 Toyo Hatsuka Kogyo Kk バクテリオフエオホ−バイド誘導体
WO1988007988A1 (en) 1987-04-17 1988-10-20 Dolphin David H Porphyrins, their syntheses and uses thereof
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
US5171741A (en) 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
JP3191223B2 (ja) * 1991-10-04 2001-07-23 株式会社光ケミカル研究所 ポルフィリン誘導体とその用途
AU682149B2 (en) * 1992-06-19 1997-09-25 Medical College Of Ohio, The Production and use of imines of porphyrins
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US6147195A (en) * 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
FR2712493B1 (fr) * 1993-11-16 1996-01-19 Centre Nat Rech Scient Utilisation de photosensibilisateurs dérivés du noyau phorbine pour la décontamination du sang infecté par des parasites et/ou des virus.
JPH09110872A (ja) * 1995-10-23 1997-04-28 Eiken Chem Co Ltd ヨードポルフィリン誘導体
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
GB9524553D0 (en) * 1995-11-30 1996-01-31 Britton Charles J Plastic lever lid tins
US5770730A (en) * 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
CA2268968C (en) * 1996-10-01 2006-10-10 Wyeth Lederle Japan, Ltd. Iminochlorin aspartic acid derivatives
IL129929A0 (en) * 1996-12-17 2000-02-29 Du Pont Polymerization of ethylene with specific iron or cobalt complexes novel pyridinebis (imines) and novel complexes of pyridinebis(imines) with iron and cobalt
RU2144538C1 (ru) * 1998-01-22 2000-01-20 Закрытое акционерное общество "Вета" Способ получения водорастворимых хлоринов
CA2353554C (en) * 1998-12-09 2011-04-26 Yeda Research And Development Co. Ltd. Palladium-substituted bacteriochlorophyll derivatives and use thereof
IL133253A0 (en) * 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
JP4277159B2 (ja) * 2000-06-02 2009-06-10 独立行政法人科学技術振興機構 新規なテトラピロリル置換ポルフィリン及びその製法
US6624187B1 (en) * 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
WO2002013820A1 (en) 2000-08-11 2002-02-21 Ceramoptec Industries, Inc. Photosensitizing ointment
DE60213996T2 (de) 2001-06-01 2007-09-06 Ceramoptec Gmbh Wasserlösliche porphyrinderivate für die photodynamische therapie, ihre verwendung und herstellung
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses

Also Published As

Publication number Publication date
ES2489516T3 (es) 2014-09-02
NO2018012I2 (no) 2018-04-10
NL300934I2 (nl) 2018-05-22
EP2522349A1 (en) 2012-11-14
NO2018012I1 (no) 2018-04-10
NO20052925D0 (no) 2005-06-15
BE2018C018I2 (no) 2023-03-07
US20200094069A1 (en) 2020-03-26
FR18C0002I2 (fr) 2020-03-13
EP1567147A2 (en) 2005-08-31
CY2018012I2 (el) 2018-09-05
CN102002048A (zh) 2011-04-06
WO2004045492A2 (en) 2004-06-03
US8461142B2 (en) 2013-06-11
BRPI0316319B8 (pt) 2021-05-25
JP4922559B2 (ja) 2012-04-25
CN102002048B (zh) 2012-11-28
AU2003282354C1 (en) 2009-10-29
HK1081858A1 (en) 2006-05-26
NZ540790A (en) 2009-12-24
EP1567147A4 (en) 2008-07-09
LUC00073I2 (en) 2018-06-20
CN1741801A (zh) 2006-03-01
AU2003282354A1 (en) 2004-06-15
AU2003282354B8 (en) 2009-05-14
JP2011162551A (ja) 2011-08-25
IL152900A0 (en) 2003-06-24
NO334978B1 (no) 2014-08-11
WO2004045492A3 (en) 2004-07-08
HUS1800020I1 (hu) 2018-05-28
JP5555659B2 (ja) 2014-07-23
PT1567147E (pt) 2014-08-25
CY1115458T1 (el) 2017-01-04
JP2011148822A (ja) 2011-08-04
US20150238773A1 (en) 2015-08-27
AU2003282354B2 (en) 2009-04-23
RU2005118771A (ru) 2006-01-20
BR0316319A (pt) 2005-09-27
DK1567147T3 (da) 2014-08-11
IL168480A (en) 2015-01-29
FR18C0002I1 (no) 2018-06-15
US20170143988A1 (en) 2017-05-25
CN1741801B (zh) 2010-12-22
US20130345417A1 (en) 2013-12-26
PL376734A1 (pl) 2006-01-09
BRPI0316319B1 (pt) 2017-06-27
CA2506296C (en) 2012-09-11
US20060142260A1 (en) 2006-06-29
RU2353624C2 (ru) 2009-04-27
JP5566945B2 (ja) 2014-08-06
EP1567147B1 (en) 2014-05-07
CA2506296A1 (en) 2004-06-03
PL216661B1 (pl) 2014-04-30
US7947672B2 (en) 2011-05-24
JP2006515836A (ja) 2006-06-08
US20110117029A1 (en) 2011-05-19
CY2018012I1 (el) 2018-09-05
MXPA05005262A (es) 2005-07-25

Similar Documents

Publication Publication Date Title
NO20052925L (no) Vannloselige anioniske bakterieklorofyllderivater og deres anvendelse
ATE534730T1 (de) Diagnose und behandlung von multiplen sulfatase- erkrankungen und anderen mit hilfe eines formylglycin bildenden enzyms
DE502007005342D1 (de) Und chirurgisches abdichtungssystem
WO2003096255A3 (en) Simulation system for medical procedures
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
UA84284C2 (ru) Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
MA29817B1 (fr) Derives de prolinamide utilises comme modulateurs du canal sodium
NO20080361L (no) Preparater og fremgangsmater for diagnostiseringer og behandlinger av tumor
BRPI0921999B8 (pt) uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
WO2006138669A3 (en) Life-like anatomic feature for testing injection of soft tissue fillers
ATE424560T1 (de) Marker für neuromyelitis optica
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
WO2009086206A3 (en) Compositions and methods for joining non-conjoined lumens
WO2006050058A3 (en) Methods of detection and therapy of inflamed tissues using immune modulation
CY1105958T1 (el) Πολυαμιδικα παραγωγα νουκλεϊκου οξεως, μεσα και μεθοδοι παρασκευης τους
WO2008016385A3 (en) Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
MX2021000882A (es) Diagnostico de la vaginosis bacteriana.
UY28912A1 (es) Procedimiento para la preparación de derivados de 1,4-difenilazetidinona
WO2007005620A3 (en) Arginase ii: a target treatment of aging heart and heart failure
DE502005010722D1 (de) Farbverändernde mittel mit moringa extrakt
CY1112012T1 (el) Αμινουχα παραγωγα β-ομοανδροστανων και β-ετεροανδροστανων
ATE495271T1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
ATE527984T1 (de) 2-amino-5-ethylphenol enthaltendes mittel zum färben von keratinfasern

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: PADELIPORFIN; REG. NO/DATE: EU/1/17/1228 20171115

Spc suppl protection certif: 2018012

Filing date: 20180410

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: PADELIPORFIN; REG. NO/DATE: EU/1/17/1228 20171115

Spc suppl protection certif: 2018012

Filing date: 20180410

Extension date: 20281117

MK1K Patent expired